-
-
-
-
-
Merck Takes Patient-Directed Approach to Bring Innovation to the Treatment of Rare Neuromuscular Dis Merck, a leading science and technology company, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for cladribine capsules for the treatment of the rare, chronic autoimmune neuromuscular disorder, generalized M资讯2025-11-25
-
-
-
-
-
-
-
最热
推荐
- 著名画家莘洪泉—传承中华文明，弘扬书法艺术
- 要炸!西安绝版小户型来了!招商揽阅大城新作重磅登场!
- 海南岛国际电影节微短剧全球峰会，听花岛荣获最佳版权方、承制方
- Samsung 连续第三年蝉联美国专利数量榜首，TSMC 跃居第二；专利授权量在经历四年下滑后增长近 4%
- CMO Council Names Daniel Ng to New Role as Advisory Board President and Regional Relationship Office
- 小柯全新排毒音乐剧《深处》 悬疑戏中戏，迷雾归来
- iCourt“国内行”项目启动，携手新东方文旅探索千年敦煌
- The Estée Lauder Companies提名Dana Strong（CBE）和Annabelle Yu Long 参选董事会成员
- 点亮湾区｜简爱·时光里再拓商业版图，双擎启动，共塑商业新地标！
- ArrowXL Optimizes Last Mile Delivery and Unlocks Capacity with Descartes